Literature DB >> 23363441

Molecular chaperone ORP150 in ER stress-related diseases.

Magdalena Kusaczuk1, Marzanna Cechowska-Pasko.   

Abstract

Many disturbances in the normal function of endoplasmic reticulum (ER) cause accumulation of unfolded proteins in the lumen of ER, triggering an evolutionary conserved response, termed the unfolded protein response (UPR). The UPR is the mechanism enabling cells to cope with unfolded proteins, accumulated in ER lumen after the cell has been exposed to various unfavorable conditions. The UPR process has strong prosurvival implications, but switches towards apoptotic cell death when the stress becomes severe and unsolvable. The hallmark of the cytoprotective branch of UPR is stimulation of the expression of ER chaperones, of which ORP150 has gained a great deal of attention. ORP150 has been identified as being overexpressed in the pathology of many diseases and is involved in the cellular response to environmental stress. Although some fragmentary results concerning ORP150 molecular activity have been presented, its exact mode of action still remains unclear. In this paper we focused on the role of ORP150 in the pathogenesis of the main types of ER stress-related diseases: diabetes, neurodegenerative diseases, cardiovascular diseases and cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23363441     DOI: 10.2174/1381612811319150016

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  18 in total

Review 1.  Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential.

Authors:  Amy S Lee
Journal:  Nat Rev Cancer       Date:  2014-04       Impact factor: 60.716

Review 2.  BiP and its nucleotide exchange factors Grp170 and Sil1: mechanisms of action and biological functions.

Authors:  Julia Behnke; Matthias J Feige; Linda M Hendershot
Journal:  J Mol Biol       Date:  2015-02-16       Impact factor: 5.469

3.  Juvenile hormone differentially regulates two Grp78 genes encoding protein chaperones required for insect fat body cell homeostasis and vitellogenesis.

Authors:  Maowu Luo; Dong Li; Zhiming Wang; Wei Guo; Le Kang; Shutang Zhou
Journal:  J Biol Chem       Date:  2017-03-29       Impact factor: 5.157

4.  Understanding the role of glucose regulated protein 170 (GRP170) as a nucleotide exchange factor through molecular simulations.

Authors:  Piyusha P Pagare; Huiqun Wang; Xiang-Yang Wang; Yan Zhang
Journal:  J Mol Graph Model       Date:  2018-09-06       Impact factor: 2.518

5.  HYOU1 facilitates proliferation, invasion and glycolysis of papillary thyroid cancer via stabilizing LDHB mRNA.

Authors:  Jia-Mei Wang; Jing-Yi Jiang; Da-Lin Zhang; Xin Du; Tong Wu; Zhen-Xian Du
Journal:  J Cell Mol Med       Date:  2021-03-31       Impact factor: 5.310

6.  Efficient induction of apoptosis by proteasome inhibitor: bortezomib in the human breast cancer cell line MDA-MB-231.

Authors:  Rafał Krętowski; Małgorzata Borzym-Kluczyk; Marzanna Cechowska-Pasko
Journal:  Mol Cell Biochem       Date:  2014-01-03       Impact factor: 3.396

7.  Hypoxia enhances the senescence effect of bortezomib--the proteasome inhibitor--on human skin fibroblasts.

Authors:  Rafał Krętowski; Małgorzata Borzym-Kluczyk; Marzanna Cechowska-Pasko
Journal:  Biomed Res Int       Date:  2014-01-29       Impact factor: 3.411

8.  Efficient apoptosis and necrosis induction by proteasome inhibitor: bortezomib in the DLD-1 human colon cancer cell line.

Authors:  Rafał Krętowski; Anna Stypułkowska; Marzanna Cechowska-Pasko
Journal:  Mol Cell Biochem       Date:  2014-10-08       Impact factor: 3.396

Review 9.  The Endoplasmic Reticulum Chaperone GRP170: From Immunobiology to Cancer Therapeutics.

Authors:  Hongxia Wang; Abdul Mohammad Pezeshki; Xiaofei Yu; Chunqing Guo; John R Subjeck; Xiang-Yang Wang
Journal:  Front Oncol       Date:  2015-01-12       Impact factor: 6.244

10.  Resveratrol exerts an anti-apoptotic effect on human bronchial epithelial cells undergoing cigarette smoke exposure.

Authors:  Li Zhang; Xialing Guo; Wang Xie; Yuping Li; Miao Ma; Ting Yuan; Bailing Luo
Journal:  Mol Med Rep       Date:  2014-11-11       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.